Skip to main content

Animations

MJFF Publications

3911 - 3920 of 8673 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00619-5
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Detection of mosaic and population-level structural variants with Sniffles2
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41587-023-02024-y
    Citation Count: 186
  • Summary Details
    OPEN
    Title: Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-023-05725-x
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Path analysis of biomarkers for cognitive decline in early Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0268379
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients
    Journal Name: Dementia and Geriatric Cognitive Disorders
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1159/000525618
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot Study
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000521232
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Reliability of Automatic Computer Vision-Based Assessment of Orofacial Kinematics for Telehealth Applications
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000525698
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete Recovery
    Journal Name: Annals of Otology, Rhinology & Laryngology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/00034894221138485
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson’s disease
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702221117147
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: Hippocampal Functional Connectivity in Parkinson’s Disease
    Journal Name: Neurodegenerative Diseases
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1159/000526377
    Best OA location URL:
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.